Paula H. Cholmondeley Bought 96% More Shares In Lexeo Therapeutics

Yahoo FinanceNov 28 05:18 ET

Baird Maintains Lexeo Therapeutics(LXEO.US) With Buy Rating, Maintains Target Price $28

Moomoo NewsNov 21 02:31 ET · Ratings

Lexeo Therapeutics' Promising Gene Therapy Progress and Strong Financial Position Present Attractive Investment Opportunity

TipRanksNov 21 01:36 ET

Here's Why We're Watching Lexeo Therapeutics' (NASDAQ:LXEO) Cash Burn Situation

Yahoo FinanceNov 20 07:09 ET

Lexeo Therapeutics Advances Cardiac Portfolio Amid Financial Report

TipRanksNov 14 23:35 ET

RBC Capital Maintains Lexeo Therapeutics(LXEO.US) With Buy Rating, Maintains Target Price $24

Moomoo NewsNov 14 21:32 ET · Ratings